Economic evaluation of three populational screening strategies for cervical cancer in the county of Valles Occidental: CRICERVA clinical trial

Home | About RECERCAT | Contact

Català | Castellano

All of RECERCAT

By Communities &
Collections By Defense Date By Authors By Titles By Subject

This Collection

By Defense Date By Authors By Titles By Subject

Statistics

View Statistics All RECERCAT

My RECERCAT

Other repositories directory

RECERCAT Home > Universitat Internacional de Catalunya > Recerca > Articles > Ciències Econòmiques i Socials > View document

To access the full text documents, please follow this link: http://hdl.handle.net/20.500.12328/1375

dc.contributor.author	Acera Pérez, Amelia
dc.contributor.author	Rodríguez, Ana
dc.contributor.author	Trapero Bertran, Marta
dc.contributor.author	Soteras, Pilar
dc.contributor.author	Sánchez, Norman
dc.contributor.author	Bonet Simó, Josep Maria
dc.contributor.author	Manresa, Josep Maria
dc.contributor.author	Hidalgo Valls, Pablo
dc.contributor.author	Torán-Monserrat, Pere
dc.contributor.author	Prieto, Gemma
dc.date	2019-12-05T10:09:29Z
dc.date	2019-12-05T10:09:29Z
dc.date	2011-10-19
dc.identifier	Acera, Amelia Rodríguez, Ana Trapero Bertran, Marta; Soteras, Pilar et al. «Economic evaluation of three populational screening strategies for cervical cancer in the county of Valles Occidental: CRICERVA clinical trial». BMC Health Services Research, 2011, vol. 11, art. 287. Disponible en: <https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-11-278>. Fecha de acceso: 05 dic. 2019. DOI: 10.1186/1472-6963-11-278
dc.identifier	1472-6963
dc.identifier	https://doi.org/10.1186/1472-6963-11-278
dc.identifier.uri	http://hdl.handle.net/20.500.12328/1375
dc.description	Background: A high percentage of cervical cancer cases have not undergone cytological tests within 10 years prior to diagnosis. Different population interventions could improve coverage in the public system, although costs will also increase. The aim of this study was to compare the effectiveness and the costs of three types of population interventions to increase the number of female participants in the screening programmes for cancer of the cervix carried out by Primary Care in four basic health care areas. Methods/Design: A cost-effectiveness analysis will be performed from the perspective of public health system including women from 30 to 70 years of age (n = 20,994) with incorrect screening criteria from four basic health care areas in the Valles Occidental, Barcelona, Spain. The patients will be randomly distributed into the control group and the three intervention groups (IG1: invitation letter to participate in the screening; IG2: invitation letter and informative leaflet; IG3: invitation letter, informative leaflet and a phone call reminder) and followed for three years. Clinical effectiveness will be measured by the number of HPV, epithelial lesions and cancer of cervix cases detected. The number of deaths avoided will be secondary measures of effectiveness. The temporal horizon of the analysis will be the life expectancy of the female population in the study. Costs and effectiveness will be discounted at 3%. In addition, univariate and multivariate sensitivity analysis will be carried out. Discussion: IG3 is expected to be more cost-effective intervention than IG1 and IG2, with greater detection of HPV infections, epithelial lesions and cancer than other strategies, albeit at a greater cost.
dc.format	7
dc.format	application/pdf
dc.language	eng
dc.publisher	BMC
dc.relation	BMC Health Services Research
dc.relation	11;287
dc.rights	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject	Cost effectiveness
dc.subject	Cost-eficàcia
dc.subject	Análisis coste-beneficio
dc.subject	Ginecologia
dc.subject	Gynecology
dc.subject	Ginecología
dc.subject	33
dc.subject	61
dc.title	Economic evaluation of three populational screening strategies for cervical cancer in the county of Valles Occidental: CRICERVA clinical trial
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/acceptedVersion

Show simple item record

All of RECERCAT

This Collection

Statistics

My RECERCAT

Related documents

Other documents of the same author